Clinical trial

3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

NCT02446847

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-11

PhasePHASE2

Study timeline

Study start (actual)2015-03-11Date precision: day

Registry last updated2020-07-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1 Infectionunresolved

Interventions

3BNC117DRUG

ART InterruptionOTHER

Sponsors & collaborators

Rockefeller Universitylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02446847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.